Figure 6
From: Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Serum HA predicts ovarian cancer progression-free survival and overall survival. A. Patients with high serum HA (> 50 μg/ml, n = 15) had a significantly reduced progression-free survival compared to patients with low serum HA (≤50 μg/mL, n = 62), log rank statistic = 6.035, P = 0.014. B. Patients with high serum HA (> 50 μg/ml, n = 16) had a significantly reduced overall survival compared to patients with low serum HA (≤50 μg/mL, n = 67), log rank statistic = 4.39, P = 0.036.